Clinical Trial Update: An Evaluation of the Efficacy and Safety of AL-46383A Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis [Phase 2]

View source ↗

Summary

This update indicates that the Phase 2 trial of AL-46383A ophthalmic solution for adenoviral conjunctivitis was terminated, with no final efficacy or safety res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoviral Conjunctivitis

Drugs mentioned

• AL-46383A ophthalmic solution

Snippet

Sponsor: Alcon Research | Conditions: Adenoviral Conjunctivitis | Phase 2 | Status: TERMINATED